PCK 3.03% 3.2¢ painchek ltd

Ann: nViso agrees perpetual global license, takes strategic stake, page-63

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 722 Posts.
    lightbulb Created with Sketch. 151
    I think any RAP holders are forgetting that RAP does not yet have any approvals , in fact they missed by a long way submission to the FDA for approval and now say they have all this testing to do , I remember a stock called PSY who said they had a revolutionary technology , only problem is they had yet to develop it into a commercial product

    RAP has been well promoted from the top down , but the risk I see is it is still a research science project, anyone out there to say RAP will get the approval for at least one of the things they are trying to do???
 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
(20min delay)
Last
3.2¢
Change
-0.001(3.03%)
Mkt cap ! $52.39M
Open High Low Value Volume
3.3¢ 3.3¢ 3.2¢ $1.155K 35.81K

Buyers (Bids)

No. Vol. Price($)
3 287786 3.1¢
 

Sellers (Offers)

Price($) Vol. No.
3.2¢ 9253 1
View Market Depth
Last trade - 14.19pm 05/11/2024 (20 minute delay) ?
PCK (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.